Redica Systems
6700 Koll Center Parkway Suite 140, Pleasanton, California, 94566, United States
Overview
Redica Systems provides Quality and Regulatory Intelligence (QRI) solutions for life sciences organizations, centered on its Catalyst Platform and supplier data offerings. The Catalyst Platform is an enterprise AI regulatory and quality solution that integrates structured and unstructured data and includes capabilities such as Redica ID for entity resolution and Redica DocIQ for processing unstructured documents. The Redica Supplier Data Network (SDN) consolidates proprietary and public datasets to create secure, comprehensive supplier profiles and supports shared audit programs, GMP document repositories, and standardized questionnaires. Redica uses AI and human-in-the-loop workflows to deliver high data accuracy, actionable insights, and enterprise adoption. The company aggregates data from over 200 global regulators to power predictive quality, compliance, and supply chain oversight. Redica is headquartered in Pleasanton, California. Redica Systems provides a data analytics platform that aggregates complete data sets from health agencies and standards bodies into quality and regulatory intelligence. Its platform connects quality assurance and regulatory surveillance to help life sciences companies solve complex GxP compliance challenges. The company serves over 200 life science companies. Led by CEO Michale de la Torre, Redica aims to improve product quality and reduce compliance risk for its customers. The firm intends to use the financing to expand its product offerings. The company is based in Pleasanton, CA. Redica Systems provides a cloud-based quality and regulatory intelligence (QRI) platform for FDA-regulated industries, including pharmaceutical, medical device, and food companies. Its platform combines proprietary data sourcing and machine learning models with purpose-built visualizations to deliver actionable, high-quality data analytics and insights. The product enables quality and safety professionals to take a risk-based approach to decision making and regulatory compliance. Redica counts 19 of the top 20 pharma companies and 9 of the top 10 medical device firms as customers. The company plans to use new funding to extend its lead as a QRI platform, fuel product innovation, accelerate customer value, and expand its total addressable market. The announcement centers on a $30 million Series B financing led by Savant Growth with participation from Rock Creek Capital. Redica Systems offers a cloud-based regulatory and compliance platform that applies data, analytics and artificial intelligence to large and disparate government and customer datasets. Its quality and regulatory intelligence (QRI) platform delivers insights to quality and safety professionals to continuously improve compliance, reduce supplier risk, and increase team efficiency. The company serves over 200 customers across pharma, medical devices and food industries, including 19 of the top 20 pharma companies and 9 of the top 10 medical device companies. Founded in 2010 and headquartered in Pleasanton, CA, Redica combines subject-matter expertise with AI-driven data to simplify regulatory enforcement and compliance workflows. Leadership says the company is focused on using actionable data intelligence to reshape how organizations think about and manage regulatory compliance. The recent financing is intended to fund that strategic roadmap and support continued growth.
- Total raised
- $49M
- Funding rounds
- 4
- Latest round
- Debt Financing
- Latest activity
- Apr 2025
Industries
- Analytics
- Artificial Intelligence (AI)
- Big Data
- Information Services
- Life Science
- Machine Learning
Recent funding
Debt Financing
Apr 2025
$15M
Series B
Dec 2021
$30M
Equity
Dec 2020
$4M